Pharmacogenomics

<p>SECTION 1</p> <p>1 Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications <br>2 Translating Pharmacogenomic Research to Therapeutic Potentials<br>3 Governmental and Academic Efforts to Advance the Field of Pharmacogenomics (PGRN CPIC, PharmGKB)</p> <p>Section 2</p> <p>4a Pharmacogenomics in Cancer Therapeutics<br>4b A Look to the Future:  Cancer epigenetics<br>5a Pharmacogenomics in Cardiovascular Diseases <br>5b A Look to the Future: Cardiovascular Pharmaco-epigenetics<br>6a Pharmacogenomics in Psychiatry Disorders<br>6b A Look to the Future: Epigenetics in psychiatric disorders and treatment<br>7 Role of Pharmacogenomics in Diabetes and Other Therapeutic Areas  </p> <p>SECTION 3</p> <p>8a Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development <br>8b Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development <br>9a Incorporating Pharmacogenomics in Drug Development<br>Part 1:  Rational  study designs for pharmacogenetic research and therapy - A perspective  from academia<br>9b Incorporating Pharmacogenomics in Drug Development <br>Part 2:  A perspective from industry <br>10 Ethnobridging and Pharmacogenomics</p> <p>SECTION 4</p> <p>11 Beyond ELSIs - Where to from here? From 'Regulator' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine<br>12 The Economics of Pharmacogenomics </p> <p>SECTION 5</p> <p>13 Integrating Genomics into Pharmacy Education and Practice: Pharmacogenomics is not enough</p>